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Neuroprotective Effect of Flavonoids: A Systematic Review
Neurodegenerative disorders such as Parkinson’s and Alzhei-
mer’s disease are underpinned by neuronal damage corollary 
to the cascade of events pitched in by neuron inflammatory 
processes. Increase in cases of neurodegenerative diseases 
and ageing population indicates the need for developing new 
strategies to prevent or treat brain dysfunction and associated 
cognitive decline. Flavonoids have been documented for various 
health promoting effects. They exert multiple neuroprotective 
actions within the brain, such as protection of neurons from neu-
rotoxins, suppression of neuron-inflammation and thus improve 
memory, learning and cognitive function. Two processes appear 
to be the basis of these effects. Firstly, they promote neuronal 
survival and synaptic plasticity by inhibition of apopotosis trig-
gered by neurotoxic species due to interaction with critical pro-
tein and lipid kinase signaling cascades. Secondly they induce 
beneficial effects on the vascular system leading to changes in 
cerebrovascular blood flow capable of causing angiogenesis, 
neurogenesis and neuronal morphology. Limiting neurodegener-
ation and prevention or reversal of age-dependent loss in cogni-
tive performance is possible by consumption of flavonoids-rich 
food throughout life. Thus flavonoids are strong candidates of 
being an important precursor molecule in the development of 
new generation of brain enhancing drugs. The present review 
accentuates current information on neuroprotective effects of fla-
vonoids.
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1. Introduction: 
Research on preventive action against age-
related neurodegeneration and potential 
modulatory neuronal function of flavonoids has 
gained profound interest recently. 
Improvements in cognition function by including 
flavonoids rich plant or food extract in humans 
and animal dietary supplementation have been 
reported indicating probable protection of 
vulnerable neurons, enhancement in existing 
neuronal function or stimulation of neuronal 
regeneration(Youdim et al. 2001). Studies have 
shown their neuroprotective potential in both, 
oxidative stress (Inanami et al. 1998) and Ab- 
induced neuronal death models(Luo et al. 
2002). Flavonoids rich gingko biloba extracts 
have been seen to exert beneficial and 
neuromodulatory effects regarding age-related 
dementias and Alzheimer’s disease 
(Bastianetto et al. 2000). In case of lesioning 
with 6-hydroxydopamine; individual flavonoids 
such as the citrus flavanone tangeretin has 
been observed to maintain nigro-striatal 
integrity and functionality, suggestive of its 
potential use as  neuroprotective agent against 
the underlying pathology associated with 
Parkinson’s disease (Datla et al. 2001). 
Reversal of certain age related decline, 
prevention of cognitive loss and memory 
associated with aging are some more beneficial 
effects of flavonoids. Flavonoids are powerful 
antioxidants in vitro, but in vivo, due to 
extensive biotransformation and conjugation 
during their absorption from gastrointestinal 
tract (GI), in the liver and finally in cells, the 
antioxidative property is limited (Evans C et al. 
1995). Phase I (hydrolyzing and oxidizing) and 
phase II (conjugating and detoxifying) reactions 
in small intestine and liver use dietary 
flavonoids (and other polyphenols) as substrate 
leaving them de-glucosylated and metabolized 
into glucuronoids, sulphates and O- methylated 
derivatives (Spencer et al. 1999). Further 
breakdown of flavonoids into simple phenolic 
acids is induced by enzymes of the gut 
microflora in the colon, which then probably 
undergoes absorption and further metabolized 
in the liver. Antioxidant potential of circulating 
metabolites of flavonoids, such as sulphates, 
glucuronoids and conjugated O- methylated 
forms, or intracellular metabolites like 
flavonoids-GSH adducts, is significantly lesser 
relative to forms found in plants (Spencer et al. 
2001). Reduction in effectiveness of such 
conjugates and metabolites in scavenging 
reactive oxygen and nitrogen species in the 
circulation is reported in comparison to their 
parent aglycones (Silva et al. 1998 and Shirai 
et al. 2001). Flavonoids must cross the blood 
brain barrier (BBB), which controls entry of 
xenobiotics into the brain, in order to access the 
brain (Bastianetto et al. 2001). Relevant in vitro 
and in situ  models have shown the passing of 
flavonones such as naringenin, hesperetin and 
their in vivo  metabolites , along with some 
dietary anthocynins pelargonidin-3-glucoside 
and cyanidine-3-rutinoside across the 
BBB.Compound lipophilicity governs the degree 
of their BBB penetration (Youdim et al. 2003), 
meaning less polar O-methylated metabolites 
may be capable to greater brain uptake than 
the more polar flavonoid glucuronoides. 
Suggestive of evidence, certain drug 
glucuronoides may cross the BBB and exert 
pharmacological effects (Kroemer et al. 1992), 
indicating specific in vivo uptake mechanism for 
glucuronoides. Their interaction with specific 
efflux transporters expressed in the BBB, such 
as P-glycoprotein may also be a factor for their 
brain entry (Lin et al. 2003), difference in in situ 
flux of quercetin and naringenin into the brain 
seems to be depending on this factor (Youdim 
et al. 2004). Post oral administrative entry of 
epigallocatechin gallate (Suganuma et al. 
1998), epicatechin and anthocyanins (D. 
Vauzour 2008) in brain has been seen in 
animals, whilst flavanones have been found in 
brain after their intravenous administration 
(Peng et al. 1998). Likewise different regions of 
rat and pig brains of blueberry fed animals have 
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shown anthocyanins, with 11 intact ones found 
in the cortex and cerebellum (Kim et al. 2001).  
2.Prevention of neurodegenerative disease: 
Sensory dysfunction and functional loss in 
neurodegenerative diseases is a result of loss 
of central nervous system (CNS) (Mattson et al. 
2004). The neurodegenerative diseases such 
as Alzheimer’s disease (AD), Parkinson’s 
disease (PD), Multiple sclerosis (MS) etc 
(Saxena et al. 2011). Show pathological signs 
which are ageing, disability and mortality. 
Prominent AD symptoms are irreversible 
memory impairment, cognitive and behavioral 
disturbances (Allan et al. 2002). Neuronal 
degeneration is caused by pathologic 
processes including oxidative stress, 
inflammation, mitochondrial dysfunction, 
apoptosis and genetic factors (Fu W et al. 
2015). Peroxidation reactions highly affect 
central nervous system which contains high 
level of polyunsaturated fatty acids. Neural cells 
are more susceptible to oxidative damage than 
other tissues because antioxidant 0activity of 
the brain is lower than other tissues. High levels 
of ascorbate in general and iron in certain 
regions of human brain is seen but CNS is not 
particularly enriched in antioxidant defense. 
Free radicals such as singlet oxygen, 
superoxide, peroxyl radicals and hydroxyl 
radicals are called reactive oxygen species 
(ROS). Various diseases like diabetes, asthma, 
carcinogenesis, arthritis, cancer, rheumatism 
and various neurodegenerative diseases are 
corollary to the damage caused by ROS to 
cellular functions. Cells or organisms protect 
themselves from these damages by the help of 
antioxidants. Loss in balance between ROS 
production and antioxidant defense causes 
oxidative stress. All medicinal plants are 
protected from oxidative damage due to 
presence of antioxidant compound. Prevention 
and therapy of various neurodegenerative 
diseases and neuronal dysfunction is aided 
essentially by natural products extracted from 
medicinal plants. Delay in neurodegeneration 
and improvement in memory and cognitive 
functions by use of polyphenolic and alkaloid 
compounds isolated from plants is suggested 
by various studies (Floyd et al. 1992). 
Flavonoids exert multiple neuroprotective 
actions within the brain, such as protection of 
neurons from neurotoxins, suppression of 
neuro-inflammation and thus improve memory, 
learning and cognitive function (Sharma et al. 
2015). Flavonoids exert anti-ageing and 
rejuvenating effects by activating various 
signaling pathways and thus protect the brain. 
Two processes appear to be the basis of these 
effects. Firstly, they promote neuronal survival 
and synaptic plasticity by inhibition of 
apopotosis triggered by neurotoxic species due 
to interaction with critical protein and lipid 
kinase signaling cascades. Secondly they 
induce beneficial effects on the vascular system 
leading to changes in cerebrovascular blood 
flow capable of causing angiogenesis, 
neurogenesis and neuronal morphology 
(Chonodrohianni et al. 2010). Prevention of 
age-related neurodisorders is a result of 
modulatory neuronal function of flavonoids 
(Rodriguez et al. 2014).Limiting 
neurodegeneration and prevention or reversal 
of age-dependent loss in cognitive performance 
is possible by consumption of flavonoids-rich 
food throughout life. Thus flavonoids are strong 
candidates of being an important precursor 
molecule in the development of new generation 
of brain enhancing drugs (Fariaa et al. 2012).  
Many of currently available drugs were 
originally isolated from plants or their 
constituents. Potential of anticholinesterase 
(Anti-Che) isolated from plants in treatment of 
Alzheimer’s disease has been investigated. 
Improvement of neuron-inflammation, 
convulsion, anxiety etc. was achieved by using 
plants and their isolated components, due to 
their anti-inflammatory and antioxidant activity, 
also presence of various complex chemical 
substances exhibit beneficial property for 
treatment of toxicity. Plant organs included in 
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herbal medicine were: leaves, flowers, roots, 
stem and seeds were used as alternative and 
complimentary therapy. Neuroprotective 
characteristic is seen in some herbs which have 
curcumin, ginsenoside, polyphenols, 
resveratrol, triptolide etc. 
 
 
Fig. 1.During child hood Dopamine level is always normal in brain. Due to Above age 50, due 
to consumption of exes alcohol, due to unhealthy life style oxidative stress will caused in brain. 
ROS(Reactive Oxygen Species) goes beyond the limit which can be stabilized by the action of 
antioxidants is called oxidative stress DNA damage and Gene mutation occur then Brain will 
effected as a results of  oxidative stress substantia nigra decrees the dopamine secretion that is 
called Neurodegeneration. Neurodegeneration caused Alzheimer disease, Parkinson disease, 
Autism and Migrain.  
 
3.Flavonoids regulate neuro-inflammatory 
proceses: 
The most common group of polyphenolic 
compounds in the human diet is flavonoids. It 
shares a common feature consisting of two 
aromatic carbon rings, benzopyran (A and C 
rings) and a benzene ring (B ring) and may be 
divided in various subgroups based on the 
degree of the oxidation of the C-ring, the 
hydroxylation pattern of the ring structure and 
the substitution of the 3-position. Following are 
some important dietary group of flavonoids: 1) 
flavones (e.g. apigenin, luteolin), which are 
found in parsley and celery; 2) flavonols (e.g. 
kaempferol, quercetin), which are found in 
onions, leeks, broccoli; 3) isoflavones (e.g. 
daidzein, genistein), which are mainly found in 
soy and soy products; 4) 
flavanones/flavanonols (e.g. hesperetin, 
naringenin/astilbin, engeletin), which are mainly 
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found in citrus fruit, herbs (oregano) and wine; 
5) flavanols (e.g. (þ)-catechin, (_)-epicatechin, 
epigallocatechin, epigallocatechin gallate 
(EGCG)), which are abundant in green tea, red 
wine, chocolate; and 6) anthocyanidins (e.g. 
pelargonidin, cyanidin, malvidin), whose 
sources include red wine and berry fruits. 
Further information regarding the structure and 
classes of flavonoids may be found in the 
thorough review by (Rodriguez-Mateos et al. 
2014). Bioavailability and biological effects of 
flavonoids greatly depend on their 
biotransformation by the liver and by the gut 
microbiota and their bioaccessibility to the brain 
inspite of being good candidates for 
neuroprotection in terms of their ability to 
modulate neuroinflammation in the central 
nervous system (CNS). Although traversal of 
flavonoids and to some extent, their metabolites 
through the blood brain barrier has been 
reported in agreement to their degree of 
lipophilicity, but it does not seem to be the sole 
factor and role of efflux transporter in brain has 
to be considered (Rodriguez-Mateos et al. 
2014). 
 
N
Flavonoids metabolits
Effect  on Brain Fuction ,Cognative performance by modulating NO
Crossing BBB
Peripheral Neurons 
Peripheral  Blood flow
Cerebrovascular Blood flow
Oxygen/Nutrient delivery Neuronal Communication
Memory and Learning
 
Fig. 2. Mechanisms underpinning the effects dietary flavonoids on memory and learning 
(Williams and Spencer, 2012). Circulating flavonoid metabolites might indirectly affect brain 
function and cognitive performance by modulating Nitric-Oxide (NO) dependent cerebrovascular 
function at the level of the cerebral endothelium or (Spencer, 2008) by crossing the Blood Brain 
Barrier (BBB), some flavonoid metabolites may act centrally by modulating neuronal receptors 
(e.g. TrkB, NMDA), signaling kinases (e.g. Akt, ERK1/2) and neurotrophins (e.g. BDNF) leading to 
changes in synaptic function.   
 
4.Effect of flavonoids on neurodegenerative 
disorders: 
Due to their therapeutic properties flavonoids 
seem to be a unique class of therapeutic 
molecules. Different flavonoids like Rutin, 
Apigenin, Hesperidin, Kaempferol, Querecetin, 
Naringenin, Astilbin, Catechin, Epicatechin, 
epigallactechin, epigallactacatechin gallate act 
in neurodegenereative diseses to protect brain 
form the neurodegenerative disorders. These 
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Flavonoids present in various medicinal plants 
have an ability to suppress neuroinflammation 
and have potential to protect brain against 
neuronal injury and promote memory, learning 
and cognitive function. (Kashniyal et al., 2016). 
 
 
 
 
Rutin Qurecitnn
ine 
Naringin  
 
Baicalein  
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Fig. 3. The Structure of Flavonoids, neuro-inflammatory, neurodegeneration, Rutin, 
Apigenin, Hesperidin, Kaempferol, Naringenin, Anthocyanins, Naringin, Baicalein, 
Catechin, epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin 
gallate(EGCG). 
 
4.1 Rutin: 
Rutin is one of the active constituents in tea 
leaves, apples and many more. Number of 
pharmacological effects of rutin, also known as 
vitamin P or rutoside, has been explored and it 
has also been observed for its nutraceutical 
effects. Apart from promoting neural crest cell 
survival, thyroid uptake and preventing neuro-
inflammation it acts as sedative, anticonvulsant, 
anti-Alzheimer,Stroke, analgesic and anti-
arthritic, showing anti-diabetic and anti-
hypercholesterolemic effects. Different effects 
are obsereved in other systems of body like: 
hypertension, blood coagulation, antiplatelet 
aggregatory effects, cardioprotective effects in 
cardiovascular system, antiulcer effects in 
gastrointestinal system, antiosteoporotic and 
antiosteopenic effect in bones, antiasthmatic 
activity and other associated effects in 
respiratory system, Diuretic effect in excretory 
system, anticataract and ophthalmic effect and 
retino-protective activity, in Eye, Sunscreen 
effects, In atopic dermatitis, effect on sperm 
quality and male reproductive organs in 
reproductive system,  body strength, prevention 
of, splenocyte and Anti fatigue activity in 
immune system It has various other protective 
functions like anticancer effects, 
Apigenin 
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chemotherapeutic activity, antibacterial activity, 
antifungal activity, antimycobacterial activity, 
larvicidal activity, antimalarial activity, 
antiretroviral activity , antiviral activity, organ 
protective effects ,neuroprotective activity 
protective effect on lung tissue, apoptosis, 
hepatoprotective activity, nephroprotective 
activity, protective effect on blood vasculature, 
wound healing activity, radio modulatory 
effects. It also participates in pharmacokinetics 
and drug interaction (Ganeshpurkar and Saluja 
2017).  
4.2 Apigenin: 
Remarkable anti-inflammatory, antioxidant and 
anti-carcinogenic properties have been 
reported in apigenin. There has been significant 
progress in studying its biological effects at 
cellular and molecular levels. Studies show the 
cancer chemopreventive effects of apigenin in 
an organ-specificity format, evaluating its 
limitations and its considerable potential for 
development as a cancer chemopreventive 
agent (Patel et al. 2007). 
4.3 Hesperidin: 
Hesperidin shows significant 7nti-inflammatory, 
analgesic, antifungal, antiviral, and anticancer 
properties (Gaur et al. 2010). Contribution to 
the intracellular antioxidant defense system and 
reduction in neuronal death are some of its 
remarkable benefits. It has also been reported 
to act as a powerful agent against superoxide, 
singlet oxygen and hydroxyl radicals(Galleano 
et al. 2010). It also has a pharmacological 
profile as a sedative and sleep-inducing 
compound in the central nervous system (CNS) 
(Marder et al. 2003). In diverse cases of 
neuronal insults such as ischemia, oxidative-
induced damage, Dopamine-induced 
neurotoxicity it exhibits neuro-protective 
property and functions as anti-amyloidogenic in 
Alzheimer’s disease (Obregon et al. 2006). 
4.4 Kaempferol:  
Plants and other foods such as apples, 
broccoli, onions and red wine naturally contain 
the flavonoid, querecetin (3,3′,4′,5,7-
pentahydroxyflavone), which exhibits 
antiapoptotic, antioxidant, pharmacological and 
cardioprotective properties (Li  et al. 2017). 
Their neuroprotective action is thought to be 
associated to the prevention of 
neurodegenerative disorders like Parkinson’s 
disease and Alzheimer’s disease (Spagnuolo et 
al. 2017). 
4.5 Naringenin: 
 A flavonoid derived from milk thistle of the 
species Silybum marianum is  Silibinin, 
(2R,3R)-3,5,7-trihydroxy-2-[(2R, 3R)-3-(4-
hydroxy-3-methoxyphenyl)-2- (hydroxymethyl)- 
2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydro-
4H -chromen-4-one (Švagera et al. 2003). 
Effects of silibinin on the inflammatory process, 
oxidative stress, autophagy (Wang et al. 2016) 
and effect of silibinin treatment on locomotor 
activity, learning, and spatial memory was 
recently investigated  by Song. In addition to 
the concentration of the proinflammatory 
cytokines IL- 1β, IL-4, and the levels of the 
antioxidant enzyme (GSH) and 
malondialdehyde (MDA), a lipid peroxidation 
marker, which occurs in response to excess 
free radicals the NF-κB (nuclear factor kappa 
B), a regulator of the immune response 
released in different situations among these 
oxidative stress, cyclooxygenase-2 (COX-2), i-
NOS (nitric oxide synthase) are products of glial 
cells contributing to an inflammatory response 
in the brain. P-53, a tumor suppressor agent, is 
a critical component of the acute stress cell 
response, and p-p53 is its phosphorylated 
component. Memory damage and spatial 
learning caused by the treatment of Aβ25-35 is 
seen to be reversed by silibinin, also 
improvement in ability to recognize new 
objects, memory flexibility and decrease in 
anxiety-like behavior has been observed. Apart 
from suppressing the expression of p-p53 and 
p-53 and inflammatory response, silibin has the 
ability to improve oxidative stress levels in the 
hippocampus. Along with neuroprotective 
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potential, silibinin especially acts on 
inflammatory response, components of 
oxidative stress, and neuronal death (Song et 
al. 2017). 
4.6 Anthocyanins: 
 Widely found in fruits, flowers, grains, and 
vegetables are polyphenolic flavonoids 
Anthocyanins (Wang et al. 2016). Along with 
memory and cognition improvement it shows 
anti-inflammatory, antioxidant and anti-
apoptosis properties (Winter et al. 2017). A 
basic flavylium core (2-phenylbenzopyryl 
cation) consisting of two aromatic rings joined 
by a three-carbon unit and condensed by an 
oxygen is the characteristic of anthocyanins. 
The anthocyanin molecule consists of two or 
three portions, an aglycone (anthocyanidin), a 
group of sugars, and often a group of organic 
acids (Smeriglio et al. 2016). Role of flavonoids 
in cognition and memory has been 
characterized with a neuroprotective factor in 
the dementias by several evidences. the ability 
of anthocyanin particles and (ethylene glycol) 
gold nanoparticles (PEG-AuNPs) (polyphenolic 
flavonoid anthocyanins for conjugation to PEG-
AuNPs) to improve memory loss and synaptic 
deficit and neurodegeneration in genetically 
modified mice (Aβ1– 42 mouse model of AD) 
has been observed by (Alim et al. 2016).   
The behavioral assessment showed that the 
latency times of the required to reach the 
hidden platform in were shorter, so number of 
platform crossings and time spent in the target 
quadrant during the probe test in mice treated 
with anthocyanins and anthocyanin-loaded 
PEG-AuNPs was increased. Furthermore, 
anthocyanins and anthocyanin-loaded PEG-
AuNPs increased the spontaneous alteration 
behavior. The levels of Aβ (β-amyloid protein), 
BACE-1 (a beta-secretase, a key enzyme in the 
formation of the β-amyloid protein), and APP 
(protein precursor antiamyloid) were found to 
be reduced in Anthocyanin-loaded PEGAuNPs 
suggestive of potential action of this flavonoids 
on the production of beta-amyloid protein. The 
administration of free anthocyanins and 
anthocyaninloaded PEG-AuNPs mitigated the 
effect of Aβ1–42 and increased the expression 
levels of synaptophysin, PSD95, and SNAP23; 
these molecules are related to the synapse 
process between the neurons. Anthocyanins 
and anthocyaninloaded PEG-AuNPs increased 
the phosphorylation of GluR1 at Ser845 and 
increased the expression level of p-CREB 
(Ser133), which can improve the memory 
process. The administration of free 
anthocyanins and anthocyaninloaded PEG-
AuNPs increased phosphorylation and elevated 
the levels of p-PI3K and p-Aktat Ser473, 
increased the level of p-GSK3β at Ser9, and 
reduced the level of p-tau at Ser413 and 
Ser404, which consequently may reduce the 
level of formation of fibrillar components. 
Reduction of the ratio of Bax/Bcl2 and Cyt c 
was observed, but anthocyanin-loaded PEG-
AuNPs were more effective than free 
anthocyanin. Reduced caspase-9, cleaved 
caspase-3, and PARP-1 levels in the 
hippocampus was also observed, and these 
results demonstrate the Neuroprotective action 
of this flavonoid. The Aβ1–42-induced-
degenerated neuronal cells in the hippocampus 
and cortex were reduced and number of 
surviving neurons incresed (Alim et al. 2016). 
Aβ1–42-induced AD mouse model was also 
investigated to study the therapeutic efficacy of 
anthocyanins alone and anthocyanin-loaded 
PEG-AuNPs. Transfer of anthocyanin-loaded 
PEG-AuNPs across the blood-brain barrier and 
accumulation in the Aβ-injected mice was 
observed. Furthermore reduced β-amyloid and 
BACE-1 expressions and prevention of tau 
hyperphosphorylation GSK-3β/ CDK5 pathway, 
by anthocyanin-loaded PEG-AuNPs was 
observed, reduced Aβ1–42-induced microglia 
and astrocyte cell activation was also seen 
(Kim et al. 2017). Another report showed 
inhibition of activated astrocytes and various 
inflammatory markers including p-NF-κB, 
inducible nitric oxide synthase (iNOS), and 
tumor necrosis factor-alpha (TNF-α) by 
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anthocyanins in the hippocampus and cortex 
regions of D-gal-treated rats. Anthocyanins are 
able to inhibit the cascade of myeloid beta-
protein production and to decrease 
synaptogenesis and neuronal death also 
microglial activation in areas important to the 
process of memory as hippocampus and cortex 
is induced by them (Rehman et al. 2017). 
4.7 Naringin: 
Grape fruit and other citrus fruits contains a 
9lavonoids Naringin (4′,5,7-trihydroxyflavanone 
7- rhamnoglucoside), belonging to a family of 
C6-C3-C6 polyphenol compounds which 
possesses anti-inflammatory antioxidative 
benefits (Qin et al. 2016). In vitro and in vivo 
studies of naringin were done using Preclinical 
models of diabetes mellitus, atherosclerosis, 
osteoporosis, cardiovascular disorders, , 
neurodegenerative disorders and 
rheumatological disorders (Bharti et al. 2014). 
Neuroprotective effect of naringin was 
demonsteted by modulation of endogenous 
biomarkers and downregulation of free radical 
and cytokines, including tumor necrosis factor- 
α (TNF-α) in streptozotocin-induced painful 
diabetic neuropathy (Kandhare et al. 2012). 
The effect of naringin against deltamethrin-
induced neurotoxicity in male Wistar rats the 
treatment lead to a significant revival of the 
oxidative status, confirming the protective effect 
of naringin. Behavioral analysis of the effect of 
naringin on memory deficit in a pharmacological 
model (donepezil and scopolamine) in animals 
has demonstrated a significant difference in the 
locomotor activity and confirmed that naringin 
has no confounding influence on locomotion on 
improving the potential for episodic memory, in 
the familiarization trial no preference or 
discrimination toward any of the objects used. 
The 9 lavonoids reversed the time induced 
episodic memory deficit increase in novel object 
exploration time compared with familiar object 
and improvement in recognition and 
discriminative indices. Therefore, naringin 
reversed the scopolamine-induced short-term 
episodic memory deficits and improved 
discrimination and recognition (Ramalingayya 
et al. 2016). The preventive effect of autophagy 
and neuroinflammation of naringin was 
investigated in a model of animal excitotoxicity 
by treatment with kainic acid (KA), a potent 
agonist of excitatory amino acids, especially 
glutamate. KA becomes a neurotoxin leading to 
neuronal death due to excitotoxicity. Significant 
decrease in the frequency of chronic 
spontaneous seizures in KA-treated mice 
compared with KA alone suggested the 
beneficial properties of naringin as an 
antiepileptic agent. Furthermore, loss of 
hippocampal neurons in the KA-treated CA1 
region was attenuated by treatment with 
naringin indicating autophagic stress reducing 
property of naringin which might otherwise be 
involved in neuronal cell death. Additionally, 
increase in TNF-α within Iba1-positive microglia 
in the KA-treated hippocampus characteristic of 
diseases such as Parkinson’s and Alzheimer’s 
due to attenuation by naringin treatment was 
reported (Jeong et al. 2015). 
4.8 Baicalein: 
A flavonoid originally isolated from the roots of 
Scutellaria baicalensis and Scutellaria lateriflora 
is Baicalein (5,6,7-trihydroxyflavone) (Makino et 
al. 2008), having antioxidant, anti-inflammatory 
properties Neuroprotective properties against 
Parkinson’s disease (Li et al. 2005).Observed 
attenuation of the motor deficits after baicalein 
treatment along with increase in striatal 
neurotransmitters: DA (dopamine), DOPAC (3, 
4-dihydroxyphenylacetic acid), and HVA 
(homovanillic acid). Increase in number of TH 
positive neurons and decreased amount of α-
syn in enteric nervous system was observed 
during analysis of fluorescence intensity by 
microscopy. Decrease of α-synoligomers, not 
monomers, was seen in ileum, thoracic spinal 
cord, and midbrain; baicalein had no effect on 
α-syn mRNA expression, indicating its 
preventive action against the progression of α-
syn accumulation in Parkinson’s disease, by 
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inhibiting the formation of α-syn oligomers (Hu 
et al. 2016). Rotenone-induced PD rats were 
used for investigating the therapeutic effects of 
baicalein and exploring whether the 
Neuroprotective potential practices by baicalein 
were through intervening in mitochondrial 
function and mitobiogenesis. Results showed 
that the motor dysfunction was partially 
ameliorated by baicalein and TH+ cells in the 
substance nigra (SN) increased in number. 
Neurons in SN were also against rotenone 
induced apoptosis. The dysfunction of 
mitochondrial complex I in the ventral midbrain 
that was damaged by rotenone was 
ameliorated by baicalein. Furthermore, the 
protein levels of PGC-1α (a regulator of 
mitochondrial mitobiogenesis), NRF-1 
(transcription factor that regulates the 
expression of antioxidant proteins), and TFAM 
(mitochondrial transcription factor) in the ventral 
midbrain, increased after the administration of 
baicalein suggestive of improvement in the 
brain’s response to oxidative stress and 
consequent neuronal loss observed in 
Parkinson’s disease (Zhang et al. 2017). 
Through a model of pharmacological 
parkinsonism in animals (MPTP administration), 
observed that in low doses, baicalein improves 
motor ability and prevented the loss of 
dopaminergic neurons caused by MPTP. 
Animal with pretreated baicalein Parkinson’s 
disease showed reduced microglial activation 
and astrocyte activation. This study reveals the 
importance of astrocyte activation for the 
occurrence of the neurodegenerative process. 
Studies show involvement of baicalein in 
reducing MPP (a toxic molecule that interferes 
with oxidative phosphorylation in mitochondria) 
that is capable of inducing the activation of NF-
κB, ERK (protein kinase intracellular signaling), 
and JNK (c-jun N-terminal kinase) in the 
astrocyte leading to a mechanism of 
neuroinflammation considered as a potent 
inducer of Parkinson’s disease (Lee et al. 
2014). Associating with its neuroprotective 
action especially on mitochondrial activity and 
activation of glial cells both of which are known 
to increasethe risk of neurodegenerative 
diseases baicalein turns out to be very effective 
against Parkinson’s disease.  
4.9 Catechin: 
For a long time, Clinical use of Chinese herbal 
medicines to treat Alzheimer’s disease has 
shown significant effectiveness (Su et al 2014). 
Catechins (flavan-3-ols) belong to the group of 
polyphenols. (−)-Epigallocatechin-3-gallate 
(EGCG), (−)-epigallocatechin (EGC), (−)-
epicatechin-3-gallate (ECG), and (−)-
epicatechin (EC) are the major polyphenols in 
green tea (Gaur and A. Kumar 2010). (Esselen 
et al. 2014)Fruits like gooseberries, kiwi, 
blueberries, apple and strawberries constitute 
catechin. Several molecular processes involved 
in angiogenesis, extracellular matrix 
degradation, the regulation of cell death, and 
multidrug resistance in cancers and related 
disorders are affected by catechin. Beneficial 
effects of catechin is mainly due to its 
antioxidant property apart from which it shows 
antihypertensive, anti-inflammatory, 
antiproliferative, antithrombogenic, and anti-
hyperlipidemic activity (Anand et al. 2014). 
5. Conclusion: On the basis of the above 
study it can be concluded that neuroprotective 
disorders dietary flavonoids number in brain, by 
neurotoxins  potential protection of  neurons 
against injury induced, it limiting 
neurodegeneration and prevention or reversal 
of age-dependent loss in cognitive performance 
is possible by consumption of flavonoids-rich 
food throughout life. Thus flavonoids are strong 
candidates of being an important precursor 
molecule in the development of new generation 
of brain enhancing drugs. ROS(Reactive 
oxygen Specese) goes beyond the limit which 
can be stabilized by the action of antioxidants is 
called oxidative stress called 
Neurodegeneration. Neurodegeneration caused 
Alzheimer desease, Parkinson desease, Autism 
and Migrain. Flavonoids, Rutin, Apigenin, 
Hesperidin, Kaempferol, Naringenin, 
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Anthocyanins, Naringin, Baicalein, Catechin, 
epicatechin, epigallocatechin, epicatechin 
gallate, epigallocatechin gallate(EGCG) shows 
Neuroprotective functions.  
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